The Effects of Atorvastatin Therapy on Rheological Characteristics of Erythrocyte Membrane, Serum Lipid Profile and Oxidative Status in Patients with Dyslipidemia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Membrane Biology

• Publication date

  2012-06-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00232-012-9441-7PMID 22706680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free Radicals in Diagnostic Medicine

  2012cited by this paper
• Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment

  2011cited by this paper
• Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.

  2011cited by this paper
• Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

  2011cited by this paper
• Electronegative Low-Density Lipoprotein is Associated with Dense Low-Density Lipoprotein in Subjects with Different Levels of Cardiovascular Risk

  2010cited by this paper
• Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.

  2010cited by this paper
• Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

  2010cited by this paper
• Influence of the Use of Statin on the Stability of Erythrocyte Membranes in Multiple Sclerosis

  2010cited by this paper
• Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

  2010influential reference
• Erythrocyte membrane composition in patients with primary hypercholesterolemia

  2009cited by this paper
• Adverse effects of statins - mechanisms and consequences.

  2009cited by this paper
• Does statin use improve pneumonia outcomes?

  2009cited by this paper
• Erythrocyte membrane composition in patients with primary hypercholesterolemia

  2008cited by this paper
• Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease

  2008cited by this paper
• Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties

  2007cited by this paper
• Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism*

  2006influential reference
• The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.

  2005cited by this paper
• Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia.

  2004influential reference
• The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status

  2002cited by this paper
• The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia

  2002influential reference
• Lipid and protein oxidation in erythrocyte membranes of hypercholesterolemic subjects.

  2001cited by this paper
• Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study.

  2000cited by this paper
• Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.

  2000cited by this paper
• Non-lipid-related effects of statins

  2000cited by this paper
• Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition.

  1996influential reference
• Influence of cholesterol-lowering on plasma membrane lipids and function.

  1996influential reference
• Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia.

  1996influential reference
• Lipid peroxides and related radicals in clinical medicine.

  1994cited by this paper
• Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.

  1993influential reference
• A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

  1993cited by this paper
• Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia.

  1992cited by this paper
• The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group.

  1991cited by this paper
• Influence of hypercholesterolemia on morphological and rheological characteristics of erythrocytes.

  1989influential reference
• Effect of diosmin upon red blood cell deformability and osmotic fragility. Relationship with lipid content.

  1988cited by this paper
• A rapid and sensitive assay for determination of cholesterol in membrane lipid extracts.

  1982cited by this paper
• An improved procedure for the preparation and measurement of (Na+ + K+)-ATPase in human erythrocytes.

  1982cited by this paper
• Erythrocyte osmotic fragility in protein-energy malnutrition: cholesterol, phospholipid, and CA2+, Mg2+ adenosine triphosphatase.

  1982cited by this paper
• The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide

  1971cited by this paper
• IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES.

  1965cited by this paper
• The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

  1963cited by this paper
• THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS.

  1947cited by this paper

• The Effect of Statin Therapy on Hemorheological Parameters of Patients with Clinically Silent Ischemic Foci of the Brain

  2025cites this paper
• Effect of Stevia rebaudiana on the attenuating effect of rosuvastatin against dexamethasone induced fatty liver disease in rats

  2024cites this paper
• Therapeutic Effect of Hijamah (Cupping Therapy) on Lipid Profiles and Apolipoprotein in Hypercholesterolemic Patients

  2022cites this paper
• Membrane Lipids and Transporter Function.

  2021cites this paper
• Estrogen-progestin oral contraceptive and nicotine exposure synergistically confers cardio-renoprotection in female Wistar rats.

  2020cites this paper
• Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol.

  2019cites this paper
• Antioxidant Effects of Baoyuan Decoction on Dysfunctional Erythrocytes in High-Fat Diet-Induced Hyperlipidemic ApoE−/− Mice

  2019cites this paper
• Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat—another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats

  2019cites this paper
• Effect of 405 nm low intensity irradiation on the absorption spectrum of in-vitro hyperlipidemia blood

  2018cites this paper
• Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease

  2018cites this paper
• Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment.

  2018cites this paper
• Simvastatin‐loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats

  2017cites this paper
• Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study.

  2017cites this paper
• Red Blood Cell Membrane Physiology In Atorvastatin Treated Rats As Evaluated By Osmofragility Test And Possible Protective Role of Coenzyme Q 10 Dr

  2017influential citation
• Red Blood Cell Membrane Physiology In Atorvastatin Treated Rats As Evaluated By Osmofragility Test And Possible Protective Role of Coenzyme Q 10

  2017cites this paper
• Alterations of hemorheological parameters and tubulin content in erythrocytes from diabetic subjects.

  2016cites this paper
• Pharmacological Effects of Atorvastatin in Platelet Function and Plaque Rupture.

  2016cites this paper
• Erythrocyte Membrane Fatty Acid Composition in Premenopausal Patients with Iron Deficiency Anemia.

  2016cites this paper
• Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation

  2016cites this paper
• Effect of Combined Ezetimibe / Atorvastatin Therapy vs . Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease : A

  2016cites this paper
• The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study.

  2016cites this paper
• Lipid-lowering efficacy of atorvastatin.

  2015cites this paper
• Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE−/− Mice

  2015cites this paper
• Influence of pravastatin chitosan nanoparticles on erythrocytes cholesterol and redox homeostasis: An in vitro study

  2015cites this paper
• Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.

  2015cites this paper
• Influence of Simvastatin Chronotherapy on Erythrocytes Nitric oxide Synthase Activity

  2015cites this paper
• Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics

  2015cites this paper
• β-Elemene reduces the progression of atherosclerosis in rabbits.

  2015cites this paper
• Simvastatin nanolipid carriers decreased hypercholesterolemia induced cholesterol inclusion and phosphatidylserine exposure on human erythrocytes

  2015cites this paper
• Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension

  2014cites this paper
• Increases in beta-lipoproteins in hyperlipidemic and dyslipidemic dogs are associated with increased erythrocyte osmotic fragility.

  2014cites this paper
• Dietary modulators of statin efficacy in cardiovascular disease and cognition.

  2014cites this paper
• Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.

  2014cites this paper
• Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol

  2014cites this paper
• Potential additive effects of garcinia cambogia on atorvastatin treated hyperlipidemic patients: randomized crossover clinical study

  2014cites this paper
• effect of simvastatin on fatty aciDs composition of erythrocyte membranes in women with chronic form of coronary heart D isease

  2013cites this paper
• Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases.

  2013cites this paper
• Bivariate and Multivariate Analyses of the Influence of Blood Variables of Patients Submitted to Roux-en-Y Gastric Bypass on the Stability of Erythrocyte Membrane against the Chaotropic Action of Ethanol

  2013cites this paper
• Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol

  2013cites this paper
• Effects of DHA-phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment.

  2012cites this paper
• Lipid lowering efficacy of atorvastatin.

  2012cites this paper